BridgeBio Pharma, Inc. (NASDAQ:BBIO) showed up in the 13F filings of 421 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 138,326 | 0.96% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 30,632 | 0.18% | $0.00 |
| Aisling Capital Management LP | 31 Dec, 2025 | 0 | -1,000,000 | -16.42% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -641,881 | -50.76% | $0.00 |
| VIKING GLOBAL INVESTORS LP | 31 Dec, 2025 | 0 | -1,583,915 | -9.91% | $0.00 |
| Frazier Life Sciences Management, L.P. | 31 Dec, 2025 | 0 | -299,900 | -7.80% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 63,598 | 479.62% | $0.00 |
| Kohlberg Kravis Roberts & Co. L.P. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -710,757 | -27.48% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 27,330 | 0.00% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 2,259,378 | 25.85% | $0.00 |
| SC US (TTGP), LTD. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| FARALLON CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | -7,385,537 | -45.08% | $0.00 |
| Polar Capital Holdings Plc | 31 Dec, 2025 | 0 | 318,288 | 32.44% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | -643,474 | -11.48% | $0.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 0 | 136,939 | 12.08% | $0.00 |
| Invesco Ltd. | 31 Dec, 2025 | 0 | 902,648 | 22.98% | $0.00 |
| Allspring Global Investments Holdings, LLC | 31 Dec, 2025 | 0 | 987,273 | 14,211.50% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 502,582 | 12.85% | $0.00 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 7,084 | 0.88% | $0.00 |